Directory
>
Arthur Tzianabos
Arthur Tzianabos
Board Member | Stoke Therapeutics
Boston, Massachusetts, United States
Arthur Tzianabos
Summary
Arthur Tzianabos is a seasoned executive with extensive experience in the biopharmaceutical and biotechnology sectors. Currently serving as CEO of Lifordi Immunotherapeutics and a Venture Partner at 5AM Ventures, he has a proven track record in clinical development, drug discovery, and commercialization. With a strong academic background, including a Post Doctoral Fellowship in Immunology from Harvard Medical School, Arthur has held various leadership roles, including Chair of the Board at Homology Medicines and Stoke Therapeutics. His career reflects a commitment to advancing life sciences and regulatory compliance, and he is known for his cross-functional team leadership skills. Arthur's diverse roles in both startups and established firms demonstrate his adaptability and strategic vision in the rapidly evolving healthcare landscape. He is also involved in educational initiatives as a Board Member at the University of New Hampshire's College of Life Sciences and Agriculture. Outside of his professional endeavors, Arthur is passionate about fostering innovation in the life sciences industry.
Arthur Tzianabos
Work Experience
Board Member at
Q32 Bio Inc.
March 2024 - Present
Chief Executive Officer at
Lifordi Immunotherapeutics, Inc.
June 2023 - Present
Venture Partner at
5AM Ventures
September 2022 - Present
Board Of Directors at
Stoke Therapeutics
September 2018 - Present
Board Member at
UNH College of Life Sciences and Agriculture
March 2018 - Present
Chair of The Board of Directors at
Q32 Bio Inc.
September 2022 - March 2024
Executive Committee Member at
Alliance for Regenerative Medicine
January 2019 - January 2024
Chair Of The Board Of Directors at
Akouos
August 2018 - December 2022
President and CEO at
Q32 Bio Inc.
March 2016 - September 2022
President and CSO at
Ovascience
September 2013 - March 2016
Sr. Vice President and Head, Research and Early Development at
SHIRE LIMITED
March 2011 - September 2013
Vice President, Program Management at
SHIRE LIMITED
December 2008 - March 2011
Sr. Director, Discovery Research at
SHIRE LIMITED
October 2005 - November 2008
Associate Professor of Medicine at
Harvard University
January 1990 - January 2005
Arthur Tzianabos
Education
Harvard Medical School, Post Doctoral Fellowship
January 1990 - January 1992
University of New Hampshire, Ph.D.
January 1985 - January 1989
Boston College, Bachelor Of Science - Bs
January 1981 - January 1985
Frequently Asked Questions about Arthur Tzianabos
What is Arthur Tzianabos email address?
Arthur Tzianabos's primary email address is ****************@unh.edu. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Arthur Tzianabos work for?
Arthur Tzianabos is a Board Member at Stoke Therapeutics, a company specializing in Commercial physical research.
Where Arthur Tzianabos graduated from?
Arthur Tzianabos holds a degree in Immunology from Harvard Medical School.
How can I directly contact Arthur Tzianabos?
To contact Arthur Tzianabos directly, you can use the email address ****************@unh.edu. Complete contact information is available upon registration with Muraena.
Who is Arthur Tzianabos?
Arthur Tzianabos is a seasoned executive with extensive experience in the biopharmaceutical and biotechnology sectors. Currently serving as CEO of Lifordi Immunotherapeutics and a Venture Partner at 5AM Ventures, he has a proven track record in clinical development, drug discovery, and commercialization. With a strong academic background, including a Post Doctoral Fellowship in Immunology from Harvard Medical School, Arthur has held various leadership roles, including Chair of the Board at Homology Medicines and Stoke Therapeutics. His career reflects a commitment to advancing life sciences and regulatory compliance, and he is known for his cross-functional team leadership skills. Arthur's diverse roles in both startups and established firms demonstrate his adaptability and strategic vision in the rapidly evolving healthcare landscape. He is also involved in educational initiatives as a Board Member at the University of New Hampshire's College of Life Sciences and Agriculture. Outside of his professional endeavors, Arthur is passionate about fostering innovation in the life sciences industry.
Arthur`s contact details
****************@unh.edu
**********@stoketherapeutics.com
**********@5amventures.com
**********@homologymedicines.com
Colleagues
Executive Director
VP Head of IT
Senior Vice President, Head of Neurology Clinical Development
Vice President of Quality
Board Member
Svp, Dmpk & Bib (Bioanalysis, Immunogenicity And Biomarkers)
Vice President, Strategy
Vice President, Controller
Executive Director, Regulatory Affairs
Chief Communications Officer